Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay

被引:58
作者
Morton, CJ
Cameron, R
Lawrence, LJ
Lin, B
Lowe, M
Luttick, A
Mason, A
McKimm-Breschkin, J
Parker, MW
Ryan, J
Smout, M
Sullivan, J
Tucker, SP
Young, PR
机构
[1] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia
[2] Biota Holdings Ltd, Melbourne, Vic 3004, Australia
[3] Biomol Res Inst, Parkville, Vic 3052, Australia
[4] Univ Queensland, Dept Microbiol & Parasitol, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia
关键词
respiratory syncytial virus; assay; fusion protein; homology model; antiviral; inhibitor;
D O I
10.1016/S0042-6822(03)00115-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Respiratory syncytial virus (RSV) is a ubiquitous human pathogen and the leading cause of lower respiratory tract infections in infants. Infection of cells and subsequent formation of syncytia occur through membrane fusion mediated by the RSV fusion protein (RSV-F). A novel in vitro assay of recombinant RSV-F function has been devised and used to characterize a number of escape mutants for three known inhibitors of RSV-F that have been isolated. Homology modeling of the RSV-F structure has been carried out on the basis of a chimera derived from the crystal structures of the RSV-F core and a fragment from the orthologous fusion protein from Newcastle disease virus (NDV). The structure correlates well with the appearance of RSV-F in electron micrographs, and the residues identified as contributing to specific binding sites for several monoclonal antibodies are arranged in appropriate solvent-accessible clusters. The positions of the characterized resistance mutants in the model structure identify two promising regions for the design of fusion inhibitors. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:275 / 288
页数:14
相关论文
共 39 条
[31]   CLUSTAL-W - IMPROVING THE SENSITIVITY OF PROGRESSIVE MULTIPLE SEQUENCE ALIGNMENT THROUGH SEQUENCE WEIGHTING, POSITION-SPECIFIC GAP PENALTIES AND WEIGHT MATRIX CHOICE [J].
THOMPSON, JD ;
HIGGINS, DG ;
GIBSON, TJ .
NUCLEIC ACIDS RESEARCH, 1994, 22 (22) :4673-4680
[32]  
Toiron C, 1996, BIOPOLYMERS, V39, P537, DOI 10.1002/(SICI)1097-0282(199610)39:4<537::AID-BIP6>3.0.CO
[33]  
2-Y
[34]   IDENTIFICATION OF A SYNTHETIC PEPTIDE AS PART OF A MAJOR NEUTRALIZATION EPITOPE OF RESPIRATORY SYNCYTIAL VIRUS [J].
TRUDEL, M ;
NADON, F ;
SEGUIN, C ;
DIONNE, G ;
LACROIX, M .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2273-2280
[35]   MTT COLORIMETRIC ASSAY SYSTEM FOR THE SCREENING OF ANTIORTHOMYXOVIRAL AND ANTI-PARAMYXOVIRAL AGENTS [J].
WATANABE, W ;
KONNO, K ;
IJICHI, K ;
INOUE, H ;
YOKOTA, T ;
SHIGETA, S .
JOURNAL OF VIROLOGICAL METHODS, 1994, 48 (2-3) :257-265
[36]   CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats [J].
Wyde, PR ;
Moore-Poveda, DK ;
O'Hara, B ;
Ding, WD ;
Mitsner, B ;
Gilbert, BE .
ANTIVIRAL RESEARCH, 1998, 38 (01) :31-42
[37]   Structural characterization of the human respiratory syncytial virus fusion protein core [J].
Zhao, X ;
Singh, M ;
Malashkevich, VN ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14172-14177
[38]   The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core [J].
Zhou, GF ;
Ferrer, M ;
Chopra, R ;
Kapoor, TM ;
Strassmaier, T ;
Weissenhorn, W ;
Skehel, JJ ;
Oprian, D ;
Schreiber, SL ;
Harrison, SC ;
Wiley, DC .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (09) :2219-2227
[39]   Proteolytic activation of respiratory syncytial virus fusion protein - Cleavage at two furin consensus sequences [J].
Zimmer, G ;
Budz, L ;
Herrler, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31642-31650